← Back to all trials
Completed
NCT04950192
Philips Intracardiac Echocardiography (ICE) Clinical Registry
Conditions: Atrial Fibrillation, Stroke, Valve Disease, Heart, Atrial Septal Defect, Patent Foramen Ovale, Mitral Valve Disease, Tricuspid Valve Disease, Aortic Valve Disease
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 155
Sponsor: Philips Clinical & Medical Affairs Global
Location: University of Colorado Aurora Colorado
Summary
The purpose of this observational registry is to report real-world safety and performance of VeriSight for ultrasound guided ICE imaging in percutaneous cardiac intervention procedures when used in standard clinical practice.
Eligibility Criteria
Inclusion Criteria:
1. 18 years of age and willing to provide written, dated and signed, informed consent
2. Scheduled for a procedure that is within the scope of clinical indication for VeriSight per Instructions for Use (IFU)
Exclusion Criteria:
1. Contraindicated for ICE catheter placement or patient considerations that make placement of VeriSight not technically feasible
2. If alternate access (as needed instead of femoral) is not viable
3. Known contraindicated conditions include sepsis, major coagulation abnormalities, presence of any intracardiac thrombus, presence of class IV angina or heart failure, deep vein thrombosis, or significant peripheral vascular disease.
Source: ClinicalTrials.gov (NCT04950192). StuddyBuddy aggregates publicly available trial information.